In conclusion, our results demonstrated that the therapeutic effects of F806 on invasion and metastasis of ESCC via inhibiting the function of Rho family proteins for regulating F-actin assemble and the combination of Paxillin with F-actin ends. The gene discussed is RHO; the disease is esophageal squamous cell carcinoma.